drugset / Trial / NCT00564031
Hormonal Replacement Therapy and Small Artery Function
RandomizedParallel-groupDouble-blindPrevention
Summary
Endothelial dysfunction in resistance arteries in women after the menopause is important for the development of high blood pressure and cardiovascular disease
Timeline
- Start
- 2003-01
- Primary completion
- —
- Completion
- 2004-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Femanest | Unknown | 2 mg | — |
| Subject | medroxyprogesterone acetate | Other / unclassified | 5 mg | — |
Indications
No indication recorded.